Milnacipran Hydrochloride

Product NDC
33342-369
11-digit product format
333420369
Labeler code
33342
Product ID
33342-369_52ad5462-ed80-417a-964f-56ef1fdce3f2
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Milnacipran Hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
Macleods Pharmaceuticals Limited
Application
ANDA210944
Marketing category
ANDA
Marketing start
2026-09-15
Substance
MILNACIPRAN HYDROCHLORIDE
Active strength
12.5 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Milnacipran Hydrochloride
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
MILNACIPRAN HYDROCHLORIDE12.5 mg/1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
33342-369-093334203690960 TABLET in 1 BOTTLE (33342-369-09) 60 tablet2026-09-15NoNoCurrent
33342-369-123334203691210 BLISTER PACK in 1 CARTON (33342-369-12) / 10 TABLET in 1 BLISTER PACK10 blister pack2026-09-15NoNoCurrent
33342-369-1533342036915500 TABLET in 1 BOTTLE (33342-369-15) 500 tablet2026-09-15NoNoCurrent